RACHEL MAGEE: Open Payments
NPI 1528805785 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $166 |
| Sumitomo Pharma America, Inc. | 1 | $52 |
| Philips North America LLC | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 2 | $31 |
| Amgen Inc. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Nubeqa, Kerendia, GEMTESA, Ambulatory Monitoring & Diagnostics Undivided, OPSYNVI, REPATHA, LifeVest, Wegovy.
Industry payments across MS — which companies pay providers there.
